Clonal hematopoiesis and mosaicism revealed by a multi-tissue analysis of constitutional TP53 status
Danielle Castillo , Tze-An Yuan , Bita Nehoray , Aleck Cervantes
Cancer Epidemiology, Biomarkers & Prevention 31 ( 8) 1621 -1629
6
2022
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
Timothy R Rebbeck , Nandita Mitra , Fei Wan , Olga M Sinilnikova
JAMA 313 ( 13) 1347 -1361
462
2015
Li-Fraumeni Exploration Consortium Data Coordinating Center: Building an Interactive Web-Based Resource for Collaborative International Cancer Epidemiology Research for a Rare Condition.
Phuong L Mai , Sharon R Sand , Neiladri Saha , Mauricio Oberti
Cancer Epidemiology, Biomarkers & Prevention 29 ( 5) 927 -935
2020
Development of a cancer genetics education program for clinicians.
Kathleen R Blazer , Grant M , Sharon R Sand , Deborah J MacDonald
Journal of Cancer Education 17 ( 2) 69 -73
11
2002
Biomarkers of response to deslorelin in women at high risk of breast cancer
Jeffrey N Weitzel , Michael F Press , Sharon R Sand , Lei Zhang
Cancer Research 78 ( 13_Supplement) 3262 -3262
2018
Reduced ovarian hormones & reduced mammographic & MRI determined breast density in BRCA carriers following a hormonal chemo-prevention regimen of gonadotropin releasing hormone agonist (GnRHA) & low-dose add-back estrogen & testosterone
Sharon R Sand , Catherine Klifa , Michael F Press , Malcolm Pike
Cancer Research 72 ( 8_Supplement) 3557 -3557
2012
Abstract PS8-15: The spectrum of germline susceptibility gene variants in Mexican patients with breast cancer (BC): A Prospective Multicenter study
Adrian Daneri-Navarro , Alejandro Mohar-Betancourt , Jeffrey N Weitzel , Sharon Sand
Cancer Research 81
2021
Germline cancer susceptibility mutations in older women with breast cancer (BC).
Yanin Chavarri Guerra , Sharon Sand , Sandra Brown , Carolyn B. Hendricks
Journal of Clinical Oncology 35
2017
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer
Jeffrey N. Weitzel , Susan L. Neuhausen , Aaron Adamson , Shu Tao
Cancer 125 ( 16) 2829 -2836
15
2019
Outcomes from intensive training in genetic cancer risk counseling for clinicians.
Kathleen R Blazer , Deborah J MacDonald , Charite Ricker , Sharon Sand
Genetics in Medicine 7 ( 1) 40 -47
27
2005
The effect of Genetic Cancer Risk Assessment (GCRA) on the uptake of risk-reducing surgeries (RRS) in Hispanic women with breast cancer (BC).
Yanin Chavarri Guerra , Kai Yang , Julio Abugattas , Sandra Brown
Journal of Clinical Oncology 36 1548 -1548
2018
Next-generation sequencing for genetic cancer risk assessment: Critical needs and perceptions of community clinicians.
Kathleen R. Blazer , Carin Espenschied , Benjamin Weissman , Sharon Sand
Journal of Clinical Oncology 31 1536 -1536
2013
The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer
Robert Pilarski , Divya A. Patel , Jeffrey Weitzel , Terri McVeigh
PLOS ONE 7 ( 5)
26
2012
Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival
Joyce Liu , Mihaela C. Cristea , Paul Frankel , Susan L. Neuhausen
Cancer Genetics 205 ( 1-2) 34 -41
35
2012
Genetic Gastric Cancer Susceptibility in the International Clinical Cancer Genomics Community Research Network
Thomas Slavin , Susan L. Neuhausen , Christina Rybak , Ilana Solomon
Cancer Genetics and Cytogenetics 216 111 -119
22
2017
Prevalence and Type of BRCA Mutations in Hispanics Undergoing Genetic Cancer Risk Assessment in the Southwestern United States: A Report From the Clinical Cancer Genetics Community Research Network
Jeffrey N. Weitzel , Jessica Clague , Arelis Martir-Negron , Raquel Ogaz
Journal of Clinical Oncology 31 ( 2) 210 -216
104
2013
Abstract PO-049: Genetic cancer risk assessment (GCRA) increases perceived personal control in Latinas at risk for hereditary breast and ovarian cancer
Charité Ricker , Bita Nehoray , Guadalupe M. Carvajal , Kathleen R. Blazer
Cancer Epidemiology and Prevention Biomarkers 29
2020
Closing the loop: action research in a multimodal hereditary cancer patient conference is an effective tool to assess and address patient needs.
Carin R. Espenschied , Deborah J. MacDonald , Julie O. Culver , Sharon Sand
Journal of Cancer Education 27 ( 3) 467 -477
4
2012
Abstract A50: Differences in perceived personal control among Latina women undergoing genetic cancer risk assessment for hereditary breast and ovarian cancer
Tanya A. Chavez , Bita Nehoray , Charité Ricker , Kathleen R. Blazer
Cancer Epidemiology, Biomarkers & Prevention 25
2016
Genetic, clinical and pathological characteristics of BRCA-associated breast cancer (BC) in Hispanic patients in the United States (US) and Latin America (LatAm).
Yanin Chavarri Guerra , Sharon Sand , Marcia Cruz Correa , Pamela Ganschow
Journal of Clinical Oncology 35 1539 -1539
2017